ASPIRAIR

Pharmaceutical preparations, sold both within inhalers and in other forms, for the prevention or treatment of diseases or conditions of the respiratory and cardiovascular systems; pharmaceutical preparations, sold both within inhalers and in other forms, for the treatment of erectile dysfunction, premature ejaculation, chronic obstructive pulmonary disease, female sexual dysfunction, migraine, asthma, viral infections in asthma and chronic obstructive pulmonary disease, lung transplant rejection, aspergillosis, cystic fibrosis, epilepsy, restless leg syndrome, sleep disorders and Parkinson's disease; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals, sold both within inhalers and in other forms, formulated for pulmonary delivery via inhalation

Drug delivery systems; drug delivery devices, namely, inhalers for medical purposes sold empty; metered dose inhalers for medical purposes sold empty; active dry powder inhalers for medical purposes sold empty; passive dry powder inhalers for medical purposes sold empty; nebulisers for respiration therapy; replacement parts and fittings for all the aforesaid goods

Printed matter, namely, printed publications in the nature of magazines, newsletters, pamphlets, reports, instructional and informational leaflets, and posters, in the fields of medicine and pharmaceuticals; paper, cardboard and goods made from these materials, namely, cardboard pharmaceutical packaging; blank patient record cards and prescription pads; pharmaceutical information leaflets; books in the fields of medicine and pharmaceuticals; packaging paper; stationery; printed instructional and teaching materials relating to the pharmaceutical, health care and medical fields